Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
actuarial, adolescent, adult, AHR, authoritative, Banc, biomarker, bladder, blind, bowel, breakage, Canton, chapter, children, CNS, constrain, cord, Corrupt, CPA, CT, distinguish, dry, Eurodollar, FCPA, holiday, humoral, inherited, inside, insider, internet, keller, Korea, layer, macula, mediated, necessity, neoplasm, NMO, OCI, older, optic, optica, Paper, plasma, postpone, raw, reborrow, repay, samalizumab, SpecimenCommon, spot, transverse, travel, uncollectable, unrestricted, variant, Vaud, vialer, visibility, william
Removed:
Abbott, acquiring, addressing, Adelphi, Adprotech, airway, aplastic, approach, Archemix, array, AstraZeneca, autoimmunity, Avant, background, Baxter, Biomedical, bronchial, Bulletin, capability, Caron, chest, CoALT, collaborator, Combinatorial, confirm, considerably, consisting, constriction, convert, creating, culmination, Daniel, Deed, deficit, devoted, directed, display, diverse, document, Dow, Dyax, EMBRACE, Emory, employed, enhancing, escrow, expended, expertise, EXPLORE, extension, favor, fellow, FIN, Fixture, flexibility, forging, formed, generation, genome, goal, guaranteed, hallmark, Imclone, Immunobiology, imposing, improve, improved, inconsequential, incurable, Indemnity, inhalation, inhaled, interaction, issuable, iStar, joining, Journal, keiser, Kingdom, Library, MAA, Medarex, MedImmune, methacholine, Microbiology, milestone, Millennium, MM, Murray, nebulizer, Neurogen, Nordisk, Novo, obsolete, occurrence, occurring, optimally, ordinary, payer, Pharma, placement, played, Polytechnic, postdoctoral, practical, privately, Prolifaron, prospective, QIAGEN, reactivity, receptor, repaid, Rother, Russell, SAB, screened, secure, simplified, Society, Southwestern, Specimen, Squibb, Stacy, standalone, substantive, suited, systemically, Tokyo, transferred, undelivered, upfront, upregulated, validated, voluntarily, vulnerable, Web, wheezing, XOMA
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2 Amendment # 1 to the Employment Agmt - DR. Leonard Bell
- 10.4 Amendment # 1 to the Employment Agmt - Stephen P. Squinto
- 10.6 Amendment # 1 to the Employment Agmt - Vikas Sinha
- 10.12 Form of Amendment No. 1 to Employment Agreements
- 10.36 Amended & Restated Credit Agreement
- 10.37 Amended & Restated Security Agreement
- 21.1 Subsidiaries
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32.1 Section 906 CEO Certification
- 32.2 Section 906 CFO Certification
Related press release
ALXN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-127471, 333-123828, 333-91265, 333-29617, 333-41397, 333-47645, 333-89343, 333-36738, 333-52886 and 333-59702) and Form S-8 (No. 333-146319, 333-139600, 333-123212, 333-119749, 333-24863, 333-52856, 333-69478, 333-71879, 333-71985, 333-106854 and 333-153612) of Alexion Pharmaceuticals, Inc. of our report dated February 23, 2010 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
Hartford, Connecticut
February 23, 2010